Furthermore, multiple studies have revealed that TCTP is overexpressed in various types of tumors, including breast cancer, digestive system tumors, lung cancer, reproductive system tumors, and hematologic malignancies, and is associated with poor clinical outcomes. Here, TPT1 is linked to lung carcinoma.